Clinical Trial

Impact of Surgical Site Infection in Peritonitis After Peritoneal Lavage With Super-oxidixed Solution

Study acronym: Plasso 2
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 6, 2024 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is randomised double blinded placebo-controlled parallel-group study. Patients in Hospital Queen Elizabeth, Sabah and Hospital Universiti Sains Malaysia, Kelantan who undergo laparotomy for peritonitis will be equally randomised into two groups : intervention group receiving super-oxidised solution and the control group receiving normal saline during peritoneal and wound lavage. This is a superiority study assessing the effectiveness of the intervention. The patient and doctors directly involved in the partient care will be blinded in this study
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-01.
Trial Details
NCT Number NCT06400394
Lead Sponsor Universiti Sains Malaysia
Collaborators: Hospital Queen Elizabeth, Malaysia
Conditions Surgical Site Infection
Enrollment 116 participants
Start Date 2024-09-01
Primary Completion 2025-10-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-06